{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:04Z","timestamp":1787026504827,"version":"build-2736575974"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["3160249, 1150862, 1070352, 1050979, 1040349, 1100926, 1110397, 1131012, 1140010, 1140011, 1150862, 1150173, 1161525, 1160695, 1140011, 3140455, 1160336"],"award-info":[{"award-number":["3160249, 1150862, 1070352, 1050979, 1040349, 1100926, 1110397, 1131012, 1140010, 1140011, 1150862, 1150173, 1161525, 1160695, 1140011, 3140455, 1160336"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["D11I1080"],"award-info":[{"award-number":["D11I1080"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00026","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T23:16:50Z","timestamp":1516231010000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution"],"prefix":"10.3389","volume":"9","author":[{"given":"Emma","family":"Rey-Jurado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mu\u00f1oz-Durango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita K.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro J.","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Genzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"B1","volume-title":"Smallpox and Its Eradication","author":"Fenner","year":"1988"},{"key":"B2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nbt0710-671","article-title":"Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India","volume":"28","author":"Padmanabhan","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B3","unstructured":"Summary of WHO position papers \u2013 recommendations for routine immunizationWHO Report2016"},{"key":"B4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine\u2014worldwide, 2016","volume":"65","author":"Hampton","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B6","volume-title":"A Guide to Introducing Inactivated Poliomyelitis Vaccine Based on the Polio Eradication & Endgame Strategic Plan 2013\u20132018","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG world atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"B11","volume-title":"TB Prevention","year":"2016"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.vaccine.2015.02.056","article-title":"Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial","volume":"33","author":"Biering-S\u00f8rensen","year":"2015","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"key":"B14","volume-title":"State of the World\u2019s Vaccines and Immunizations","year":"2009"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1016\/j.vaccine.2015.05.050","article-title":"Cost-effectiveness of Haemophilus influenzae type B vaccine in Vietnam","volume":"33","author":"Le","year":"2015","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12879-016-1485-3","article-title":"Streptococcus pneumoniae and Haemophilus influenzae type B carriage in Chinese children aged 12\u201318 months in Shanghai, China: a cross-sectional study","volume":"14","author":"Hu","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B17","volume-title":"Pentavalent Supply and Procurement Roadmap 2016 Update","year":"2016"},{"key":"B18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jinf.2013.11.013","article-title":"The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy","volume":"68","author":"Cromer","year":"2014","journal-title":"J Infect"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/irv.12036","article-title":"Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"7","author":"Savy","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1513\/AnnalsATS.201609-721OC","article-title":"Real-time surveillance of influenza morbidity: tracking intensive care unit resource utilization","volume":"14","author":"Baker","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e20172550","DOI":"10.1542\/peds.2017-2550","article-title":"Recommendations for prevention and control of influenza in children, 2017\u20132018","volume":"140","year":"2017","journal-title":"Pediatrics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1016\/j.vaccine.2017.07.053","article-title":"Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004\u20132015): the 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness","volume":"35","author":"Palache","year":"2017","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12879-017-2432-7","article-title":"Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1","volume":"17","author":"Kwok","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7774\/cevr.2017.6.1.22","article-title":"Tetanus\u2013diphtheria\u2013acellular pertussis vaccination for adults: an update","volume":"6","author":"Lee","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1824-7288-40-29","article-title":"Prevalence and socio-demographic factors associated with non-protective immunity against tetanus among high school adolescents girls in Nigeria","volume":"40","author":"Orimadegun","year":"2014","journal-title":"Ital J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13643-015-0053-z","article-title":"The burden of pertussis in low- and middle-income countries since the inception of the expanded programme on immunization (EPI) in 1974: a systematic review protocol","volume":"1","author":"Muloiwa","year":"2015","journal-title":"Syst Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijporl.2016.04.024","article-title":"Diphtheria: it is still prevalent!!!","volume":"86","author":"Jain","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1186\/s12889-016-3844-9","article-title":"Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems","volume":"16","author":"Solano","year":"2016","journal-title":"BMC Public Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1586\/14760584.2015.1037289","article-title":"The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011\u20132012 US pertussis epidemic","volume":"14","author":"Wolf","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B32","first-page":"385","article-title":"Pertussis","volume-title":"Immunization, Vaccines and Biologicals","year":"2010"},{"key":"B33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7774\/cevr.2014.3.2.168","article-title":"Current status of human papillomavirus vaccines","volume":"3","author":"Kim","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/infdis\/jiw639","article-title":"Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France","volume":"215","author":"Heard","year":"2016","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12887-017-0804-1","article-title":"Factors associated with parental reasons for \u201cno-intent\u201d to vaccinate female adolescents with human papillomavirus vaccine: national immunization survey \u2013 teen 2008\u20132012","volume":"17","author":"Cheruvu","year":"2017","journal-title":"BMC Pediatr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B37","first-page":"49","article-title":"Weekly epidemiological record. Rotavirus vaccines WHO position paper \u2013 January 2013","volume":"88","year":"2013","journal-title":"WHO report"},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40249-016-0173-2","article-title":"Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis","volume":"5","author":"Santos","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1365-2567.2008.02805.x","article-title":"The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific","volume":"124","author":"Bueno","year":"2008","journal-title":"Immunology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1365-2567.2012.03614.x","article-title":"Mechanisms used by virulent Salmonella to impair dendritic cell function and evade adaptive immunity","volume":"137","author":"Bueno","year":"2012","journal-title":"Immunology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12879-016-1351-3","article-title":"Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies","volume":"29","author":"Mogasale","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"20592","DOI":"10.2807\/1560-7917.ES2013.18.39.20592","article-title":"Increase in Salmonella enterica serovar Paratyphi A infections in Phnom Penh, Cambodia, January 2011 to August 2013","volume":"18","author":"Vlieghe","year":"2013","journal-title":"Euro Surveill"},{"key":"B46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterisation of Gal E mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"1","author":"Levine","year":"1987","journal-title":"Lancet"},{"key":"B48","first-page":"45","article-title":"A challenge study to asses the protective efficacy of typhoid Vi-polysaccharide-protein conjugate vaccine in laboratory animals","volume":"1","author":"Venkatesan","year":"2011","journal-title":"Int J Curr Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CVI.00791-13","article-title":"Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India","volume":"21","author":"Ochiai","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1016\/j.vaccine.2017.09.066","article-title":"A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever","volume":"35","author":"Howlader","year":"2017","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijmm.2016.11.006","article-title":"Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998\u20132012","volume":"307","author":"Das","year":"2017","journal-title":"Int J Med Microbiol"},{"key":"B53","volume-title":"Control of Epidemic Meningococcal Disease 2nd edition. WHO Practical Guidelines","year":"1996"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998\u20132007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"key":"B55","first-page":"129","article-title":"Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire. Meningococcal disease in countries of the African meningitis belt, 2012-emerging needs and future perspectives","volume":"12","year":"2013","journal-title":"World Health Organization reports"},{"key":"B56","unstructured":"Vaccines and Preventable Diseases. What Types of Meningococcal Vaccines Are There?2017"},{"key":"B57","first-page":"57","article-title":"Meningococcal meningitis","volume-title":"Immunization, Vaccines and Biologicals","year":"2015"},{"key":"B58","article-title":"Meningococcus","volume-title":"Vaccine Resource Library","year":"2017"},{"key":"B59","doi-asserted-by":"publisher","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the African meningitis belt, 2004\u20132013","volume":"15","author":"Lingani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S594","DOI":"10.1093\/cid\/civ508","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt","volume":"61","author":"Karachaliou","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/20477724.2016.1274068","article-title":"Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa","volume":"111","author":"Mohammed","year":"2017","journal-title":"Pathog Glob Health"},{"key":"B64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/0974-777X.77299","article-title":"Fundamentals of vaccine immunology","volume":"3","author":"Clem","year":"2011","journal-title":"J Glob Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1016\/j.vaccine.2015.09.067","article-title":"Freeze-dried live attenuated smallpox vaccine prepared in cell culture \u201cLC16-KAKETSUKEN\u201d: post-marketing surveillance study on safety and efficacy compliant with good clinical practice","volume":"33","author":"Nishiyama","year":"2015","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1956","DOI":"10.1128\/mBio.01956-15","article-title":"Vaccine and wild-type strains of yellow fever virus engage distinct entry mechanisms and differentially stimulate antiviral immune responses","volume":"7","author":"Fernandez-Garcia","year":"2016","journal-title":"MBio"},{"key":"B67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jpids\/piu034","article-title":"Post-licensure surveillance of trivalent live-attenuated influenza vaccine in children aged 2\u201318 years, vaccine adverse event reporting system, United States, July 2005\u2013June 2012","volume":"4","author":"Haber","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution of Th1 and Th17\u2009cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0150700","DOI":"10.1371\/journal.pone.0150700","article-title":"Influenza vaccine manufacturing: effect of inactivation, splitting and site of manufacturing. Comparison of influenza vaccine production processes","volume":"11","author":"Kon","year":"2016","journal-title":"PLoS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4161\/hv.27124","article-title":"Live attenuated hepatitis A vaccines developed in China","volume":"10","author":"Xu","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1128\/AAC.49.11.4700-4707.2005","article-title":"Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency","volume":"49","author":"Mej\u00edas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1128\/CVI.05117-11","article-title":"Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague","volume":"18","author":"Kumar","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nbt1261","article-title":"Vaccine manufacturing: challenges and solutions","volume":"24","author":"Ulmer","year":"2006","journal-title":"Nat Biotechnol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1016\/j.vaccine.2014.07.074","article-title":"Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process","volume":"32","author":"Buckland","year":"2014","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4161\/hv.23233","article-title":"A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores","volume":"9","author":"Chichester","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2015\/504831","article-title":"Current and emerging cell culture manufacturing technologies for influenza vaccines","volume":"2","author":"Mili\u00e1n","year":"2015","journal-title":"Biomed Res Int"},{"key":"B78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2217\/fmb.10.161","article-title":"Safety of MDCK cell culture-based influenza vaccines","volume":"6","author":"Gregersen","year":"2011","journal-title":"Future Microbiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1016\/j.vaccine.2015.09.022","article-title":"A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03","volume":"33","author":"Naruse","year":"2015","journal-title":"Vaccine"},{"key":"B80","first-page":"419","article-title":"The avian EB66(R) cell line, application to vaccines, and therapeutic protein production","volume":"64","author":"Brown","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1016\/j.vaccine.2017.08.021","article-title":"Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M\u2122 adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.1016\/j.vaccine.2009.06.023","article-title":"Production of yellow fever virus in microcarrier-based Vero cell cultures","volume":"27","author":"Souza","year":"2009","journal-title":"Vaccine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1586\/14760584.2016.1162104","article-title":"Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less","volume":"15","author":"Schiffer","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","article-title":"Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production","volume":"100","author":"Tapia","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/bit.25545","article-title":"Improved virus purification processes for vaccines and gene therapy","volume":"112","author":"Nestola","year":"2015","journal-title":"Biotechnol Bioeng"},{"key":"B86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1478-7547-11-23","article-title":"Drug versus vaccine investment: a modelled comparison of economic incentives","volume":"11","author":"R\u00e9gnier","year":"2013","journal-title":"Cost Eff Resour Alloc"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.vaccine.2009.11.007","article-title":"The expanding vaccine development pipeline, 1995\u20132008","volume":"28","author":"Davisa","year":"2010","journal-title":"Vaccine"},{"key":"B88","first-page":"464","article-title":"Modified vaccinia virus ankara (MVA) \u2013 development as recombinant vaccine and prospects for use in veterinary medicine","volume":"128","author":"Volz","year":"2015","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9935","DOI":"10.1007\/s00253-015-6842-4","article-title":"Selection and optimization of transfection enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures","volume":"99","author":"Cervera","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1016\/j.vaccine.2016.04.089","article-title":"Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: an effective influenza vaccine candidate","volume":"34","author":"Venereo-Sanchez","year":"2016","journal-title":"Vaccine"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.4161\/hv.25181","article-title":"A novel, disruptive vaccination technology: self-adjuvanted RNActive(\u00ae) vaccines","volume":"9","author":"Kallen","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4939-3618-2_28","article-title":"Protocols for developing novel chikungunya virus DNA vaccines","volume":"1426","author":"Chung","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B94","volume-title":"World Population Projected to Reach 9.7 Billion by 2050","year":"2015"},{"key":"B95","volume-title":"Global Vaccine Market Features and Trends","author":"Kaddar","year":"2008"},{"key":"B96","doi-asserted-by":"publisher","first-page":"a021014","DOI":"10.1101\/cshperspect.a021014","article-title":"Licensing biotech intellectual property in university\u2013industry partnerships","volume":"5","author":"Drozdoff","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/COH.0000000000000322","article-title":"Pox-protein public private partnership program and upcoming HIV vaccine efficacy trials","volume":"11","author":"Russell","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"B98","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-med-051215-030919","article-title":"Toward an effective ebola virus vaccine","volume":"68","author":"Keshwara","year":"2017","journal-title":"Annu Rev Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2471\/BLT.13.133298","article-title":"Impact of BRICS\u2019 investment in vaccine development on the global vaccine market","volume":"92","author":"Kaddar","year":"2014","journal-title":"Bull World Health Organ"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1016\/j.vaccine.2007.09.007","article-title":"Access to vaccine technologies in developing countries: Brazil and India","volume":"25","author":"Milstiena","year":"2017","journal-title":"Vaccine"},{"key":"B101","unstructured":"WHO Vaccine-Preventable Diseases: Monitoring System2017"},{"key":"B102","unstructured":"European Center for Disease Prevention an Control. Vaccine Schedule2017"},{"key":"B103","first-page":"1","volume":"6","year":"2006","journal-title":"Newsletter on Vaccine and Immunization"},{"key":"B104","first-page":"69","article-title":"\u00dcberblick \u00fcber die Epidemiologie der Masern in 2014 und aktuelle Situation in 2015 in Deutschland","volume":"10","year":"2015","journal-title":"Epidemiol Bull"},{"key":"B105","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s15010-016-0926-7","article-title":"Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015","volume":"44","author":"Jablonka","year":"2016","journal-title":"Infection"},{"key":"B106","volume-title":"Birth-18 Years & \u201cCatch-Up\u201d Immunization Schedules","year":"2017"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.15585\/mmwr.mm6539a4","article-title":"Vaccination coverage among children aged 19\u201335 months \u2013 United States, 2015","volume":"65","author":"Hill","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2105\/AJPH.2015.302967","article-title":"Use of fees to discourage nonmedical exemptions to school immunization laws in US states","volume":"106","author":"Billington","year":"2016","journal-title":"Am J Public Health"},{"key":"B109","unstructured":"Immmunization in the Americas2016"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e0153141","DOI":"10.1371\/journal.pone.0153141","article-title":"Effectiveness of the 10-valent pneumococcal conjugate vaccine (PCV-10) in children in Chile: a nested case-control study using nationwide pneumonia morbidity and mortality surveillance data","volume":"11","author":"Diaz","year":"2016","journal-title":"PLoS One"},{"key":"B111","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1478-7547-11-21","article-title":"A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries","volume":"11","author":"Mart\u00ed","year":"2013","journal-title":"Cost Eff Resour Alloc"},{"key":"B112","unstructured":"Recommended Routine Immunization2017"},{"key":"B113","volume-title":"Assessment Report of the Global Vaccine Action Plan. Strategic Advisory Group of Experts on Immunization","year":"2017"},{"key":"B114","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/heapol\/czp047","article-title":"Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia","volume":"25","author":"Grundy","year":"2010","journal-title":"Health Policy Plan"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1086\/420748","article-title":"Financing immunizations in the United States","volume":"38","author":"Hinman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"173e176","DOI":"10.1016\/j.biologicals.2009.02.011","article-title":"The Brazilian vaccine manufacturers\u2019 perspective and its current status","volume":"37","author":"Homma","year":"2009","journal-title":"Biologicals"},{"key":"B117","first-page":"1","article-title":"How much money is spent on vaccines across Western European countries?","volume":"25","author":"Ethgen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1016\/j.vaccine.2016.02.067","article-title":"Quality vaccines for all people: report on the 16th annual general meeting of the developing countries vaccine manufacturers\u2019 network, 05\u201307th October 2015, Bangkok, Thailand","volume":"34","author":"Pagliusi","year":"2016","journal-title":"Vaccine"},{"key":"B119","doi-asserted-by":"publisher","first-page":"B176","DOI":"10.1016\/j.vaccine.2012.11.060","article-title":"Developing countries vaccine manufacturers network: doing good by making high-quality vaccines affordable for all","volume":"31","author":"Pagliusi","year":"2013","journal-title":"Vaccine"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.vaccine.2008.01.034","article-title":"The developing countries vaccine manufacturers\u2019 network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries","volume":"26","author":"Jadhav","year":"2008","journal-title":"Vaccine"},{"key":"B121","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.publhealth.27.021405.102248","article-title":"Vaccine shortages: history, impact, and prospects for the future","volume":"27","author":"Hinman","year":"2006","journal-title":"Annu Rev Public Health"},{"key":"B122","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.vaccine.2011.11.075","article-title":"Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States","volume":"30","author":"Santibanez","year":"2012","journal-title":"Vaccine"},{"key":"B123","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000440701","article-title":"The Moreau strain of bacillus Calmette-Guerin (BCG) for high-risk non-muscle invasive bladder cancer: an alternative during worldwide BCG shortage?","volume":"96","author":"Hofbauer","year":"2016","journal-title":"Urol Int"},{"key":"B124","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12916-016-0685-4","article-title":"The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality","volume":"14","author":"Harris","year":"2016","journal-title":"BMC Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/S0140-6736(15)61050-9","article-title":"Vaccine shortage threatens spread of meningitis in Niger","volume":"385","author":"Maurice","year":"2015","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amepre.2007.07.038","article-title":"Impact of a severe influenza vaccine shortage on primary care practice","volume":"33","author":"Kempe","year":"2007","journal-title":"Am J Prev Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B128","doi-asserted-by":"publisher","first-page":"457","DOI":"10.15585\/mmwr.mm6617e2","article-title":"Addressing a yellow fever vaccine shortage \u2013 United States, 2016\u20132017","volume":"66","author":"Gershman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(01)07185-9","article-title":"Shortage of vaccines during a yellow fever outbreak in Guinea","volume":"358","author":"Nathan","year":"2001","journal-title":"Lancet"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e1165","DOI":"10.1542\/peds.2007-0037","article-title":"Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001\u20132005 national immunization survey","volume":"120","author":"Smith","year":"2007","journal-title":"Pediatrics"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1542\/peds.2008-1092","article-title":"Temporary vaccine recommendations and provider compliance: a survey of pediatric practices during the 2003\u20132004 pneumococcal conjugate vaccine shortage","volume":"22","author":"Groom","year":"2008","journal-title":"Pediatrics"},{"key":"B132","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu Rev Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1016\/j.vaccine.2016.08.019","article-title":"The 2015 global production capacity of seasonal and pandemic influenza vaccine","volume":"34","author":"McLean","year":"2016","journal-title":"Vaccine"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e13256","DOI":"10.1371\/journal.pone.0013256","article-title":"Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico","volume":"5","author":"Zepeda-Lopez","year":"2010","journal-title":"PLoS One"},{"key":"B135","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1086\/499587","article-title":"Vaccine supply problems: a perspective of the centers for disease control and prevention","volume":"42","author":"Rodewald","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B136","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1473-3099(14)70999-5","article-title":"The development of global vaccine stockpiles","volume":"15","author":"Yen","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B137","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/maq.12339","article-title":"Bioseguridad in Mexico: pursuing security between local and global biologies","volume":"31","author":"Wanderer","year":"2017","journal-title":"Med Anthropol Q"},{"key":"B138","unstructured":"Pandemic (H1N1) 20092010"},{"key":"B139","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1743-422X-6-51","article-title":"Towards a sane and rational approach to management of influenza H1N1 2009","volume":"6","author":"Gallaher","year":"2009","journal-title":"Virol J"},{"key":"B140","volume-title":"Ebola Virus Disease","year":"2016"},{"key":"B141","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.apjtm.2016.05.020","article-title":"Zika virus, a pathway to new challenges","volume":"9","author":"Jamil","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N Engl J Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/jpm-2016-0220","article-title":"Prenatal screening for microcephaly: an update after three decades","volume":"45","author":"Gelber","year":"2017","journal-title":"J Perinat Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543784","article-title":"Monoclonal antibodies for the treatment of ebola virus disease","volume":"8","author":"Moekotte","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored ebola vaccines: a randomized clinical trial","volume":"15","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"B146","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.coviro.2017.03.008","article-title":"Immunomonitoring of human responses to the rVSV-ZEBOV ebola vaccine","volume":"23","author":"Medaglini","year":"2017","journal-title":"Curr Opin Virol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ebiom.2016.09.028","article-title":"Preventative vaccines for zika virus outbreak: preliminary evaluation","volume":"13","author":"Kim","year":"2016","journal-title":"EBioMedicine"},{"key":"B148","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3201\/eid1901.120310","article-title":"Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998\u20132010","volume":"19","author":"Sanchez","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1056","article-title":"Regional epidemiology of methicillin-resistant Staphylococcus aureus among adult intensive care unit patients following state-mandated active surveillance","author":"Lin","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268817002680","article-title":"Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections","volume":"12","author":"Ukah","year":"2017","journal-title":"Epidemiol Infect"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0114","article-title":"Rifampicin resistance and multidrug-resistant tuberculosis detection using Xpert MTB\/RIF in Wuhan, China: a retrospective study","author":"Huang","year":"2017","journal-title":"Microb Drug Resist"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s11255-017-1627-6","article-title":"Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully","volume":"49","author":"Patwardhan","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"B153","volume-title":"Global Action Plan on Antimicrobial Resistance","year":"2015"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00026\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T09:51:46Z","timestamp":1526377906000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00026\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2018.00026"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00026","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"article-number":"26"}}